Eli Lilly has become the latest pharmaceutical company to be accused of bribery in China amidst a string of allegations directed at big drugs companies including Britain’s GSK.
The US drugmaker Eli Lilly has been accused of bribing Chinese doctors to prescribe its drugs. The company has said it is “deeply concerned” about the allegations. These fresh allegations of bribery, estimated to be worth £3.1m according to the Chinese newspaper 21st Century Business Herald, are not the first to be levelled at Lilly.…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
